Cancer-specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells

Cancer Discovery

Volumn 3, Issue 2, 2013, Pages 198-211

  Ding, Yu ^a   Hubert, Christopher G ^b   Herman, Jacob ^g   Corrin, Philip ^a   Toledo, Chad M ^a   Skutt Kakaria, Kyobi ^a,f   Vazquez, Julio ^c   Basom, Ryan ^d   Zhang, Bin ^e   Risler, Jennifer K ^d   Pollard, Steven M ^h   Nam, Do Hyun ⁱ   Delrow, Jeffery J ^d   Zhu, Jun ^c   Lee, Jeongwu ^j   DeLuca, Jennifer ^g   Olson, James M ^b   Paddison, Patrick J ^a  

^a Division of Human Biology   (United States)

^b Clinical Research Division   (United States)

^c Scientific Imaging Shared Resource   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e SAGE BIONETWORKS   (United States)

^f EVERGREEN STATE COLLEGE   (United States)

^g Department of Environmental and Radiological Health Sciences   (United States)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ Samsung Medical Center   (South Korea)

^j LERNER RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BUB1 RELATED PROTEIN; MONASTROL;

ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CELL GROWTH; CELL PROLIFERATION; CENTROMERE; CHROMOSOME ANALYSIS; CHROMOSOME STRUCTURE; CONTROLLED STUDY; DNA BARCODING; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GLIOBLASTOMA; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; MOUSE; NEURAL STEM CELL; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STEM CELL EXPANSION; TUMOR CELL; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; BINDING SITES; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE; CELL LINE, TRANSFORMED; CELL PROLIFERATION; GENETIC PREDISPOSITION TO DISEASE; GLIOBLASTOMA; HELA CELLS; HUMANS; KINETOCHORES; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; MITOTIC SPINDLE APPARATUS; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 84873929643     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-12-0353     Document Type: Article

References (50)

1. American Cancer Society. American Cancer Society: Cancer Facts and Figures 2010. [cited 2013 Jan 15]. Available from: http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-and-figures-2010.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolo-mide for glioblastoma. N Engl J Med 2005; 352: 987-96.
3. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 2003; 100: 15178-83.
4. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-8.
5. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
6. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural pre-cursors from human glioblastoma. Cancer Res 2004; 64: 7011-21.
7. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9: 391-403.
8. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009; 4: 568-80.
9. Stiles CD, Rowitch DH. Glioma stem cells: a midterm exam. Neuron 2008; 58: 832-46.
10. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756-60.
11. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, et al. Stem cell-like glioma cells promote tumor angiogenesis through vas-cular endothelial growth factor. Cancer Res 2006; 66: 7843-8.
12. Liu Q, Nguyen DH, Dong Q, Shitaku P, Chung K, Liu OY, et al. Molecu-lar properties of CD133 + glioblastoma stem cells derived from treat-ment-refractory recurrent brain tumors. J Neurooncol 2009; 94: 1-19.
13. Sawin KE, LeGuellec K, Philippe M, Mitchison TJ. Mitotic spin-dle organization by a plus-end-directed microtubule motor. Nature 1992; 359: 540-3.
14. Hartwell LH, Szankasi P, Roberts CJ, Murray AW, Friend SH. Integrat-ing genetic approaches into the discovery of anticancer drugs. Science 1997; 278: 1064-8.
15. Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009; 462: 108-12.
16. Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF, et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 2009; 137: 835-48.
17. Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 2007; 8: 379-93.
18. Sun Y, Pollard S, Conti L, Toselli M, Biella G, Parkin G, et al. Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Mol Cell Neurosci 2008; 38: 245-58.
19. Lens SM, Voest EE, Medema RH. Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer 2010; 10: 825-41.
20. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core path-ways. Nature 2008; 455: 1061-8.
21. Zhu J, Zhang B, Smith EN, Drees B, Brem RB, Kruglyak L, et al. Inte-grating large-scale functional genomic data to dissect the complexity of yeast regulatory networks. Nat Genet 2008; 40: 854-61.
22. Tran LM, Zhang B, Zhang Z, Zhang C, Xie T, Lamb JR, et al. Inferring causal genomic alterations in breast cancer using gene expression data. BMC Syst Biol 2011; 5: 121.
23. Yang X, Deignan JL, Qi H, Zhu J, Qian S, Zhong J, et al. Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nat Genet 2009; 41: 415-23.
24. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant sub-types of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010; 17: 98-110.
25. Son MJ, Woolard K, Nam DH, Lee J, Fine HA. SSEA-1 is an enrich-ment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 2009; 4: 440-52.
26. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998; 392: 300-3.
27. Bie L, Zhao G, Cheng P, Rondeau G, Porwollik S, Ju Y, et al. The accu-racy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expression. PLoS ONE 2011; 6: e25631.
28. Yuan B, Xu Y, Woo JH, Wang Y, Bae YK, Yoon DS, et al. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin Cancer Res 2006; 12: 405-10.
29. Santaguida S, Musacchio A. The life and miracles of kinetochores. EMBO J 2009; 28: 2511-31.
30. DeLuca JG, Moree B, Hickey JM, Kilmartin JV, Salmon ED. hNuf2 inhibition blocks stable kinetochore-microtubule attachment and induces mitotic cell death in HeLa cells. J Cell Biol 2002; 159: 549-55.
31. DeLuca JG, Gall WE, Ciferri C, Cimini D, Musacchio A, Salmon ED. Kinetochore microtubule dynamics and attachment stability are regulated by Hec1. Cell 2006; 127: 969-82.
32. Maresca TJ, Groen AC, Gatlin JC, Ohi R, Mitchison TJ, Salmon ED. Spindle assembly in the absence of a RanGTP gradient requires local-ized CPC activity. Curr Biol 2009; 19: 1210-5.
33. Uchida KS, Takagaki K, Kumada K, Hirayama Y, Noda T, Hirota T. Kinetochore stretching inactivates the spindle assembly checkpoint. J Cell Biol 2009; 184: 383-90.
34. Lampson MA, Kapoor TM. The human mitotic checkpoint protein BubR1 regulates chromosome-spindle attachments. Nat Cell Biol 2005; 7: 93-8.
35. DeLuca KF, Lens SM, DeLuca JG. Temporal changes in Hec1 phos-phorylation control kinetochore-microtubule attachment stability during mitosis. J Cell Sci 2011; 124: 622-34.
36. Malureanu LA, Jeganathan KB, Hamada M, Wasilewski L, Davenport J, van Deursen JM. BubR1 N terminus acts as a soluble inhibitor of cyclin B degradation by APC/C(Cdc20) in interphase. Dev Cell 2009; 16: 118-31.
37. Tang Z, Bharadwaj R, Li B, Yu H. Mad2-independent inhibition of APCCdc20 by the mitotic checkpoint protein BubR1. Dev Cell 2001; 1: 227-37.
38. Davenport J, Harris LD, Goorha R. Spindle checkpoint function requires Mad2-dependent Cdc20 binding to the Mad3 homology domain of BubR1. Exp Cell Res 2006; 312: 1831-42.
39. Harris L, Davenport J, Neale G, Goorha R. The mitotic checkpoint gene BubR1 has two distinct functions in mitosis. Exp Cell Res 2005; 308: 85-100.
40. Mao Y, Desai A, Cleveland DW. Microtubule capture by CENP-E silences BubR1-dependent mitotic checkpoint signaling. J Cell Biol 2005; 170: 873-80.
41. Wang X, Babu JR, Harden JM, Jablonski SA, Gazi MH, Lingle WL, et al. The mitotic checkpoint protein hBUB3 and the mRNA export factor hRAE1 interact with GLE2p-binding sequence (GLEBS)-containing proteins. J Biol Chem 2001; 276: 26559-67.
42. Wang Q, Liu T, Fang Y, Xie S, Huang X, Mahmood R, et al. BUBR1 defi-ciency results in abnormal megakaryopoiesis. Blood 2004; 103: 1278-85.
43. Elowe S, Dulla K, Uldschmid A, Li X, Dou Z, Nigg EA. Uncoupling of the spindle-checkpoint and chromosome-congression functions of BubR1. J Cell Sci 2010; 123: 84-94.
44. Park DM, Rich JN. Biology of glioma cancer stem cells. Mol Cells 2009; 28: 7-12.
45. Sudakin V, Yen TJ. Targeting mitosis for anti-cancer therapy. BioDrugs 2007; 21: 225-33.
46. Wood KW, Lad L, Luo L, Qian X, Knight SD, Nevins N, et al. Anti-tumor activity of an allosteric inhibitor of centromere-associated protein-E. Proc Natl Acad Sci U S A 2010; 107: 5839-44.
47. Zecevic M, Catling AD, Eblen ST, Renzi L, Hittle JC, Yen TJ, et al. Active MAP kinase in mitosis: localization at kinetochores and associ-ation with the motor protein CENP-E. J Cell Biol 1998; 142: 1547-58.
48. Liao H, Li G, Yen TJ. Mitotic regulation of microtubule cross-linking activity of CENP-E kinetochore protein. Science 1994; 265: 394-8.
49. Sonoda Y, Ozawa T, Hirose Y, Aldape KD, McMahon M, Berger MS, et al. Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res 2001; 61: 4956-60.
50. Veiseh M, Gabikian P, Bahrami SB, Veiseh O, Zhang M, Hackman RC, et al. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraopera-tive visualization of cancer foci. Cancer Res 2007; 67: 6882-8.